Robert Corona, DO, MBA, named associate dean for academic and industry relations and chief innovation officer

Robert Corona, DO, MBA, has been named associate dean for academic and industry relations and chief innovation officer at Upstate Medical University.

The appointment was announced by President Danielle Laraque-Arena, MD, FAAP.

As associate dean for academic and industry relations, Corona will report to College of Medicine Dean Julio Licinio, MD; as chief innovation officer, Corona will report to Laraque-Arena and serve on the university’s executive committee.

“Dr. Corona is an innovative thinker with the ability to find common ground and collaborative opportunities between academic medicine and industry,” said Laraque-Arena. “His record of success in medicine and industry make him well suited to formulate an innovation strategy that will not only strengthen our campus’s entrepreneurial spirit, but broaden our connections with industry that can benefit our local economy.”

As associate dean for academic and industry relations and chief innovation officer, Corona will build and nurture an innovative ecosystem at Upstate. He will be responsible for formalizing and communicating Upstate’s innovation strategy, optimizing the processes and governance that will lead to incentivizing creativity and scientific and entrepreneurial growth.

College of Medicine Dean Julio Licinio, MD, PhD, said: “Bringing research from the bench to clinical use requires effective commercialization. Dr. Corona’s new role will be critical to both enhancing our translational pipeline and to generating resources for further research and development that will facilitate new discoveries.”

Corona will strengthen Upstate’s academic mission through public-private partnerships with industry and industry leaders creating the necessary synergies to provide students and faculty with experiential opportunities that will allow them to flourish in the ever-changing health care and biomedical environments.

Most recently, Corona has led the development and implementation of the Upstate MIND (Medical Innovation and Novel Discovery) at the CNY Biotech Accelerator that provides space, technology and access to expert guidance to see a discovery through to commercialization aimed at benefiting the biomedical sciences and ultimately patient care. The Upstate MIND last month selected a handful of entrepreneurs to pursue the development of products for the Medical Device Innovation Challenge.

Corona will continue to serve as the John B. Henry Professor and chair of the Department of Pathology and Laboratory Medicine, medical director of Neuropathology and vice president for innovation and business development.

Corona founded Upstate’s telemedicine program while at Upstate in the 1990s. He also served as chief medical officer and vice president of Medical and Scientific Affairs at Welch Allyn Inc. in Skaneateles.

Corona received his doctor of osteopathic medicine degree from New York Institute of Technology College of Osteopathic Medicine. He subsequently performed clinical training including a rotating internship at Southeastern Medical Center in Miami, followed by training in neurology, anatomic pathology and neuropathology at Upstate, with special fellowships in neuropathology at the Armed Forces Institute of Pathology. He received his MBA from the University of Massachusetts at Amherst. He is board certified in anatomic pathology, neuropathology and clinical informatics by the American Board of Pathology and medical management and certified physician executive by the American College of Physician Executives.

A member of many state and national organizations, he has served as a member of the Board of Directors of the American Osteopathic Foundation, a member of the Federation of State Medical Boards Working Group on Telemedicine, and as an appointed member of the Office of Professional Medical Conduct, New York State Department of Health. He is an emeritus member of the New York State Board for Medicine.

Back to Feature Stories →</